SREBF1 and non-alcoholic fatty liver: Folic acid has therapeutic effects in rats with HFD-induced NAFL, as well as a function in modulating hepatic miR-21, -34a, and -122 and their target genes (HBP1, SIRT1, and SREBP-1c, respectively).